Author | Luke Nordquist, MD, FACP | OncLive

Author | Luke Nordquist, MD, FACP

Articles

Dr. Luke Nordquist on Radium-223 Retreatment

August 04, 2016

Video

Luke Nordquist, MD, FACP, a urologic medical oncologist and CEO of the Urology Cancer Center and GU Research Network, discusses a multicenter, prospective study of radium-223 retreatment in metastatic castration-resistant prostate cancer (mCRPC).

x